Loading...
01/09 23:13
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance with a 50.7% revenue increase and a 57.1% net income rise, driven by enrollment growth and program expansion. Despite competitive pressures and regulatory challenges, the company maintains a strong cash position and minimal debt. The Q&A session confirms strong program performance, particularly in nursing and imaging, although some uncertainty remains regarding future acquisitions and seasonality impacts. Overall, the positive financial results and strategic focus on growth initiatives suggest a likely positive stock price movement.
Revenue $18.6 million (50.7% increase year-over-year from $12.3 million), driven by a 70.7% increase in new student starts and a 49.8% growth in ending enrollment.
Net Income $2.8 million (57.1% increase year-over-year from $1.8 million), reflecting strong operational execution and revenue growth.
EPS $0.21 per diluted share (up from $0.19 per diluted share), correlating with the increase in net income.
Adjusted EBITDA $3.9 million (60% increase year-over-year from $2.4 million), indicating improved profitability and operational efficiency.
Educational Services Revenue $10.1 million (54.4% of revenue, up from $6.5 million or 53.1% of revenue), due to investments in instructional staff and program support.
General and Administrative Expenses $4.6 million (24.9% of revenue, up from $3.3 million or 26.8% of revenue), driven by higher marketing and professional fees.
Cash and Cash Equivalents $17.3 million, indicating strong liquidity for future investments.
Working Capital $22 million, providing ample liquidity for growth initiatives.
Total Assets $67.1 million, reflecting the company's financial stability.
Stockholders’ Equity $39.3 million, indicating a solid equity position.
Net Cash from Operating Activities $4.7 million, showcasing strong cash flow generation.
Debt $1 million, indicating minimal debt levels and strong financial positioning.
New Programs: Launching new offerings in high-demand fields, including sterile processing, surgical technician, and EMT.
Market Expansion: Acquisition of Contra Costa Medical Career College added 468 students and expanded footprint in high-demand healthcare markets.
Enrollment Growth: Achieved a 70.7% increase in new student starts and a 49.8% growth in ending enrollment, reaching 3,245 students.
Operational Efficiency: Expanded hybrid learning models leveraging advanced simulation technology to enhance training and increase student flexibility.
Strategic Shifts: Focusing on cost optimization while investing in technology and faculty to enhance the student experience.
Acquisition Strategy: Actively evaluating additional acquisition targets and branch locations to expand geographic and programmatic reach.
Competitive Pressures: Legacy Education faces competitive pressures in the healthcare education sector, necessitating continuous innovation and marketing efforts to attract new students.
Regulatory Issues: The company must navigate evolving regulatory dynamics, ensuring compliance with Title IV and accreditation standards, which could impact operations and growth.
Supply Chain Challenges: While not explicitly mentioned, the integration of Contra Costa Medical Career College and expansion plans may involve supply chain challenges related to staffing and resources.
Economic Factors: The demand for healthcare professionals is influenced by broader economic conditions, which could affect enrollment and job placement rates.
Enrollment Growth: Legacy Education achieved a 70.7% increase in new student starts, reaching 1,227 students in Q3 2025.
Program Expansion: Plans to launch new programs in high-demand fields such as sterile processing, surgical technician, and EMT.
Acquisition Strategy: Successfully integrated Contra Costa Medical Career College and are actively evaluating additional acquisition targets.
Operational Efficiency: Focus on cost optimization while investing in technology and faculty to enhance the student experience.
Revenue Growth: Expect continued momentum in revenue growth driven by strong enrollment and program expansion.
Cash Position: Maintain a strong cash position of $17.3 million, providing flexibility for future investments.
Market Demand: Anticipate sustained demand for healthcare professionals, supporting enrollment and program offerings.
Future Investments: Plan to invest in new programs, branch expansions, and technology upgrades.
Net Income: $2.8 million or $0.21 per diluted share
Cash and Cash Equivalents: $17.3 million
Working Capital: $22 million
Debt: $1 million
The earnings call revealed strong financial performance with a 38.5% revenue growth and a 9.6% increase in EBITDA, despite margin decline due to strategic investments. The Q&A section highlighted a robust acquisition pipeline and strategic capacity planning. Although management was vague on certain details, overall sentiment was positive due to strong enrollment momentum, new program launches, and strategic partnerships. This suggests a likely positive stock price movement in the short term.
The earnings call revealed strong financial performance with significant revenue and net income growth. Despite some concerns about enrollment dependence and economic uncertainties, management demonstrated operational efficiency and a robust balance sheet. The Q&A highlighted capacity expansions and new program launches, though management was cautious with forward guidance. Overall, the positive financial metrics and strategic expansions suggest a positive stock price movement.
The earnings call highlights strong financial performance with a 50.7% revenue increase and a 57.1% net income rise, driven by enrollment growth and program expansion. Despite competitive pressures and regulatory challenges, the company maintains a strong cash position and minimal debt. The Q&A session confirms strong program performance, particularly in nursing and imaging, although some uncertainty remains regarding future acquisitions and seasonality impacts. Overall, the positive financial results and strategic focus on growth initiatives suggest a likely positive stock price movement.
The earnings call reveals strong financial performance with significant revenue growth (50.7% YoY) and increased net income (57.1% YoY). The company maintains a robust cash position and low debt, indicating financial health. Product development and business updates, including new program approvals and successful integration of an acquisition, support growth. Despite some lack of clarity in the Q&A, the overall sentiment is positive, driven by strong financial metrics, optimistic guidance, and strategic expansion efforts. The market reaction is likely to be positive, with a potential stock price increase of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
